Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucri...
Q1 2026
May 12, 2026
FY 2025
Dec 31, 2025
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 12, 2025